Topics

Device helps paralyzed patients regain hand control through direct brain signal reading, advancing accessible neurotechnology for spinal cord injuries.

The U.S. Food and Drug Administration (FDA) is rapidly integrating AI into its regulatory processes, aiming to enhance efficiency and reduce review times across all centers.